Cargando…

Red Cell Distribution Width Association with Subclinical Cardiovascular Disease in Patients with Rheumatoid Arthritis

Red cell distribution width (RDW) is a measure of the variation in mean corpuscular volume that reflects the degree of anisocytosis on the peripheral blood smear. RDW value variation has been implicated in several disorders including chronic inflammatory processes and cardiovascular (CV) diseases. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Sierra, Marta, Romo-Cordero, Alejandro, Quevedo-Abeledo, Juan C., Quevedo-Rodríguez, Adrián, Gómez-Bernal, Fuensanta, de Vera-González, Antonia, López-Mejías, Raquel, Martín-González, Candelaria, González-Gay, Miguel Ángel, Ferraz-Amaro, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607716/ https://www.ncbi.nlm.nih.gov/pubmed/37892635 http://dx.doi.org/10.3390/jcm12206497

Ejemplares similares

Mean Platelet Volume in a Series of 315 Patients with Rheumatoid Arthritis: Relationship with Disease Characteristics, including Subclinical Atherosclerosis and Cardiovascular Comorbidity
por: González-Sierra, Marta, et al.
Publicado: (2023)

The Ratio of Monocytes to HDL-Cholesterol Is Associated with Cardiovascular Risk and Insulin Resistance in Patients with Rheumatoid Arthritis
por: Romo-Cordero, Alejandro, et al.
Publicado: (2023)

Relationship of Blood Inflammatory Composite Markers with Cardiovascular Risk Factors and Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
por: González-Sierra, Marta, et al.
Publicado: (2023)

Blood Composite Scores in Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Júlia, et al.
Publicado: (2023)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2023)

Relationship between Disease Characteristics and Circulating Interleukin 6 in a Well-Characterized Cohort of Patients with Systemic Lupus Erythematosus
por: Mercader-Salvans, Julia, et al.
Publicado: (2023)

Relationship between Malondialdehyde Serum Levels and Disease Features in a Full Characterized Series of 284 Patients with Systemic Lupus Erythematosus
por: Merino de Paz, Nayra, et al.
Publicado: (2023)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
por: Gómez-Bernal, Fuensanta, et al.
Publicado: (2022)

Relationship of Fibroblast Growth Factor 23 Serum Levels with Disease Characteristics in Systemic Lupus Erythematosus Patients
por: Fernández-Cladera, Yolanda, et al.
Publicado: (2023)

Apolipoprotein C-III is linked to the insulin resistance and beta-cell dysfunction that are present in rheumatoid arthritis
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
por: García-González, María, et al.
Publicado: (2023)

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

SCORE2 versus SCORE in patients with systemic lupus erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Metabolic Syndrome in Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Incretins in patients with rheumatoid arthritis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
por: Ferraz-Amaro, Iván, et al.
Publicado: (2022)

Malondialdehyde Serum Levels in Patients with Systemic Sclerosis Relate to Dyslipidemia and Low Ventricular Ejection Fraction
por: Ibrahim-Achi, Zeina, et al.
Publicado: (2023)

Proprotein convertase subtilisin/kexin type 9 is related to disease activity and damage in patients with systemic erythematosus lupus
por: Sánchez-Pérez, Hiurma, et al.
Publicado: (2020)

Response to ‘Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis’
por: Gonzalez-Gay, Miguel A, et al.
Publicado: (2014)

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2017)

Cerebral Small Vessel Disease Associated with Subclinical Vascular Damage Indicators in Asymptomatic Hypertensive Patients
por: Hernández-Díaz, Zenaida Milagros, et al.
Publicado: (2019)

Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients
por: López-Mejías, Raquel, et al.
Publicado: (2015)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Impaired beta cell function is present in nondiabetic rheumatoid arthritis patients
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Red Cell Distribution Width in Rheumatoid arthritis
por: Al-Rawi, Ziad S., et al.
Publicado: (2018)

Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
por: Rodríguez-Rodríguez, Luis, et al.
Publicado: (2012)

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
por: Rodríguez-Hernández, Orvelindo, et al.
Publicado: (2023)

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis
por: López-Mejías, Raquel, et al.
Publicado: (2016)

Early Mortality of Brain Infarction Patients and Red Blood Cell Distribution Width
por: Lorente, Leonardo, et al.
Publicado: (2020)

Association between red blood cell distribution width and mortality of COVID-19 patients
por: Lorente, Leonardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bovd30l3j8q8to17f8bgfvsjtg